Reimbursed with a limitationOriginator productATC C10AA05

Sortis

Sortis is an originator product from Viatris Pharma GmbH and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 37.75 to CHF 86.65 depending on the pack; the patient co-payment is 40 per cent plus the deductible.

Core data

Authorisation holder
Viatris Pharma GmbH
ATC code
C10AA05
IT group
07.12 Blutlipidsenkende Mittel
Active substances
Atorvastatinum
Preparation type
Originator product
On the SL since
15/03/1998
Last price change
01/08/2022
Co-payment
40%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Sortis Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Filmtabl 10 mg30 StkCHF 20.05CHF 37.7501/08/2002B7680540850285
Filmtabl 10 mg100 StkCHF 65.97CHF 86.6015/03/1998B7680540850360
Filmtabl 20 mg30 StkCHF 20.05CHF 37.7515/03/1998B7680540850445
Filmtabl 20 mg100 StkCHF 65.97CHF 86.6015/03/1998B7680540850520
Filmtabl 40 mg30 StkCHF 20.05CHF 37.7501/08/2002B7680540850605
Filmtabl 40 mg100 StkCHF 65.97CHF 86.6001/08/2002B7680540850797
Filmtabl 80 mg30 StkCHF 20.05CHF 37.7501/11/2005B7680540851091
Filmtabl 80 mg100 StkCHF 65.97CHF 86.6501/11/2005B7680540851176

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/08/2022

Bei Erwachsenen ab 18 bis und mit 75 Jahren wird eine Behandlung mit Statinen vergütet im Rahmen der Sekundärprävention kardiovaskulärer Ereignisse sowie im Rahmen der Primärprävention bei Personen mit hohem oder sehr hohem Risiko nach AGLA-Risikokategorie sowie bei Personen mit einem Risiko von über 1% nach AGLA-Risikokategorie. Eine entsprechend bis und mit 75 Jahren gestartete Statin-Therapie wird auch nach Vollendung des 75. Lebensjahres weiter vergütet.
Bei Personen über 75 Jahren wird eine neu beginnende Statin-Therapie nur vergütet im Rahmen der Sekundärprävention kardiovaskulärer Ereignisse sowie im Rahmen der Primärprävention bei Personen mit hohem oder sehr hohem Risiko nach AGLA-Risikokategorie.

More preparations in this group

FAQ

Is Sortis covered by Swiss health insurance?

Yes, but only under conditions. Sortis is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Sortis cost in Switzerland?

The public price is the maximum price set by the FOPH and for Sortis ranges from CHF 37.75 to CHF 86.65 per pack. The ex-factory price ranges from CHF 20.05 to CHF 65.97. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com